title: Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy.
abstract: The Raf-MEK-ERK pathway is commonly activated in human cancers, largely attributable to the extracellular signal-regulated kinases (ERKs) being a common downstream target of growth factor receptors, Ras, and Raf. Elevation of these up-stream signals occurs frequently in a variety of malignancies and ERK kinases play critical roles in promoting cell proliferation. Therefore, inhibition of MEK-mediated ERK activation is very appealing in cancer therapy. Consequently, numerous MEK inhibitors have been developed over the years. However, clinical trials have yet to produce overwhelming support for using MEK inhibitors in cancer therapy. Although complex reasons may have contributed to this outcome, an alternative possibility is that the MEK-ERK pathway may not solely provide proliferation signals to malignancies, the central scientific rationale in developing MEK inhibitors for cancer therapy. Recent developments may support this alternative possibility. Accumulating evidence now demonstrated that the MEK-ERK pathway contributes to the proper execution of cellular DNA damage response (DDR), a major pathway of tumor suppression. During DDR, the MEK-ERK pathway is commonly activated, which facilitates the proper activation of DDR checkpoints to prevent cell division. Inhibition of MEK-mediated ERK activation, therefore, compromises checkpoint activation. As a result, cells may continue to proliferate in the presence of DNA lesions, leading to the accumulation of mutations and thereby promoting tumorigenesis. Alternatively, reduction in checkpoint activation may prevent efficient repair of DNA damages, which may cause apoptosis or cell catastrophe, thereby enhancing chemotherapy's efficacy. This review summarizes our current understanding of the participation of the ERK kinases in DDR.
authors.affiliation: Division of Nephrology, Department of Medicine, McMaster University, Ontario, Canada.
authors.forename: F
authors.initials: F
authors.lastname: Wei
authors.forename: J
authors.initials: J
authors.lastname: Yan
authors.forename: D
authors.initials: D
authors.lastname: Tang
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D004249:DNA Damage / Q000187:drug effects*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D020935:MAP Kinase Signaling System / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D047428:Protein Kinase Inhibitors / Q000378:metabolism / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D048049:Extracellular Signal-Regulated MAP Kinases
references.citation: Biol Cell. 2009 Aug 19;101(11):617-27
references.pmid: 19686094
references.citation: Cancer Cell. 2004 Oct;6(4):313-9
references.pmid: 15488754
references.citation: DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1219-25
references.pmid: 15279810
references.citation: DNA Repair (Amst). 2008 Mar 1;7(3):487-96
references.pmid: 18249159
references.citation: Nature. 2006 Jan 19;439(7074):358-62
references.pmid: 16273091
references.citation: J Biol Chem. 2002 Apr 12;277(15):12710-7
references.pmid: 11821415
references.citation: J Biol Chem. 2000 Nov 17;275(46):35778-85
references.pmid: 10958792
references.citation: Oncogene. 2007 May 14;26(22):3227-39
references.pmid: 17496918
references.citation: Oncogene. 2007 Jul 12;26(32):4689-98
references.pmid: 17297454
references.citation: Am J Pathol. 2010 Mar;176(3):1203-14
references.pmid: 20075200
references.citation: J Natl Cancer Inst. 2009 Feb 4;101(3):136-8
references.pmid: 19176464
references.citation: Mol Cell Biol. 2001 Feb;21(3):755-64
references.pmid: 11154263
references.citation: Nat Rev Mol Cell Biol. 2008 Aug;9(8):616-27
references.pmid: 18594563
references.citation: Cell Signal. 2010 Nov;22(11):1783-9
references.pmid: 20637859
references.citation: DNA Repair (Amst). 2009 Mar 1;8(3):286-97
references.pmid: 19144573
references.citation: Oncogene. 2010 Dec 9;29(49):6428-41
references.pmid: 20802529
references.citation: Nat Rev Cancer. 2010 Nov;10(11):760-74
references.pmid: 20966921
references.citation: Oncogene. 2003 Sep 1;22(37):5885-96
references.pmid: 12947395
references.citation: Biochim Biophys Acta. 2007 Aug;1773(8):1263-84
references.pmid: 17126425
references.citation: Nature. 2005 Mar 31;434(7033):605-11
references.pmid: 15758953
references.citation: Cell. 1994 Jun 17;77(6):841-52
references.pmid: 7911739
references.citation: Adv Cancer Res. 2009;102:1-17
references.pmid: 19595305
references.citation: Blood. 2011 Aug 25;118(8):2035-43
references.pmid: 21693757
references.citation: J Assoc Res Otolaryngol. 2007 Sep;8(3):338-55
references.pmid: 17516123
references.citation: Cancer Res. 2007 Feb 1;67(3):1046-53
references.pmid: 17283137
references.citation: Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H1956-65
references.pmid: 18775851
references.citation: Mol Cell. 2009 Aug 14;35(3):327-39
references.pmid: 19683496
references.citation: J Cell Biol. 2009 Dec 28;187(7):977-90
references.pmid: 20026654
references.citation: Mol Cell Biol. 2007 May;27(9):3367-77
references.pmid: 17339343
references.citation: Science. 2004 Apr 2;304(5667):93-6
references.pmid: 15064416
references.citation: Science. 2003 Jun 6;300(5625):1542-8
references.pmid: 12791985
references.citation: Nature. 2003 Jan 30;421(6922):499-506
references.pmid: 12556884
references.citation: Genes Dev. 1999 Jun 15;13(12):1501-12
references.pmid: 10385618
references.citation: Cancer Res. 2005 Nov 1;65(21):9834-42
references.pmid: 16267006
references.citation: J Biol Chem. 2000 Dec 15;275(50):39435-43
references.pmid: 10993883
references.citation: Cell. 2006 Mar 10;124(5):943-55
references.pmid: 16530042
references.citation: Oncogene. 2006 Feb 23;25(8):1153-64
references.pmid: 16186792
references.citation: J Biol Chem. 1993 Jul 15;268(20):14553-6
references.pmid: 8325833
references.citation: EMBO J. 2009 Oct 21;28(20):3067-73
references.pmid: 19779456
references.citation: Cancer Lett. 2009 Oct 8;283(2):125-34
references.pmid: 19217204
references.citation: Cell Signal. 2010 Jan;22(1):47-56
references.pmid: 19766185
references.citation: Nat Cell Biol. 2005 Jul;7(7):675-85
references.pmid: 15965469
references.citation: Nat Rev Mol Cell Biol. 2005 Nov;6(11):827-37
references.pmid: 16227978
references.citation: Clin Cancer Res. 2009 May 1;15(9):3050-7
references.pmid: 19366835
references.citation: Oncotarget. 2011 Mar;2(3):135-64
references.pmid: 21411864
references.citation: Mol Cancer Res. 2010 Nov;8(11):1547-57
references.pmid: 20870738
references.citation: Oncogene. 2005 May 5;24(20):3285-96
references.pmid: 15735702
references.citation: J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S474-5
references.pmid: 21102245
references.citation: DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1025-32
references.pmid: 15279789
references.citation: Cell Signal. 2007 Jun;19(6):1113-20
references.pmid: 17391916
references.citation: Genes Dev. 1999 Jan 15;13(2):163-75
references.pmid: 9925641
references.citation: Science. 2005 Apr 22;308(5721):551-4
references.pmid: 15790808
references.citation: J Biol Chem. 2008 Jul 11;283(28):19511-20
references.pmid: 18482985
references.citation: J Invest Dermatol. 2008 Oct;128(10):2403-11
references.pmid: 18463681
references.citation: Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8302-5
references.pmid: 10890907
references.citation: PLoS One. 2011 Jan 25;6(1):e15561
references.pmid: 21283624
references.citation: Cancer Cell. 2011 Jan 18;19(1):11-5
references.pmid: 21251612
references.citation: Nature. 2000 Nov 23;408(6811):433-9
references.pmid: 11100718
references.citation: Mol Cell Biol. 1997 Jun;17(6):3103-15
references.pmid: 9154809
references.citation: Cell Signal. 2011 Jan;23(1):259-68
references.pmid: 20840867
references.citation: Cell Cycle. 2011 Feb 1;10(3):481-91
references.pmid: 21263216
references.citation: EMBO J. 2000 Nov 1;19(21):5801-12
references.pmid: 11060031
references.citation: Curr Opin Mol Ther. 2010 Dec;12(6):674-83
references.pmid: 21154159
references.citation: Genes Dev. 2008 Jun 1;22(11):1478-89
references.pmid: 18519640
references.citation: Genes Dev. 2008 Jun 1;22(11):1416-21
references.pmid: 18519633
references.citation: Genes Dev. 2000 Aug 15;14(16):2046-59
references.pmid: 10950868
references.citation: Toxicol Sci. 2009 Aug;110(2):307-18
references.pmid: 19487340
references.citation: Biol Cell. 2001 Sep;93(1-2):53-62
references.pmid: 11730323
references.citation: Mol Cell. 2003 Jan;11(1):203-13
references.pmid: 12535533
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13827-32
references.pmid: 14605214
references.citation: Oncotarget. 2011 Apr;2(4):336-46
references.pmid: 21505228
references.citation: J Cell Physiol. 2007 Mar;210(3):784-97
references.pmid: 17117479
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1633-8
references.pmid: 12578958
references.citation: Mol Biol Cell. 2005 May;16(5):2372-81
references.pmid: 15743907
references.citation: Mech Ageing Dev. 2005 Nov;126(11):1146-58
references.pmid: 16087220
references.citation: Mol Carcinog. 2010 Apr;49(4):353-62
references.pmid: 20358631
references.citation: Blood. 2008 Sep 15;112(6):2439-49
references.pmid: 18614762
references.citation: J Biol Chem. 2005 Feb 11;280(6):4632-8
references.pmid: 15557324
references.citation: DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1009-14
references.pmid: 15279787
references.citation: J Biol Chem. 2009 Mar 13;284(11):6705-15
references.pmid: 19147494
references.citation: Cell Cycle. 2006 Jun;5(12):1265-8
references.pmid: 16760665
references.citation: Biochem J. 2000 Oct 15;351 Pt 2:289-305
references.pmid: 11023813
references.citation: Nat Cell Biol. 2004 Jul;6(7):665-72
references.pmid: 15195100
references.citation: Genes Dev. 2007 Jun 15;21(12):1472-7
references.pmid: 17575048
references.citation: Trends Biochem Sci. 2000 Sep;25(9):448-53
references.pmid: 10973059
references.citation: Apoptosis. 2009 Sep;14(9):1108-20
references.pmid: 19548087
references.citation: Free Radic Biol Med. 2009 Jun 1;46(11):1543-50
references.pmid: 19324081
references.citation: Mol Cell. 2010 Oct 22;40(2):179-204
references.pmid: 20965415
references.citation: EMBO J. 1992 Aug;11(8):2909-17
references.pmid: 1639063
references.citation: J Clin Invest. 2003 Mar;111(6):877-85
references.pmid: 12639994
references.citation: Science. 1997 Sep 5;277(5331):1501-5
references.pmid: 9278512
references.citation: Science. 2001 Nov 23;294(5547):1713-6
references.pmid: 11721054
references.citation: J Biol Chem. 2007 Sep 21;282(38):28036-44
references.pmid: 17636252
references.citation: Clin Cancer Res. 2009 Oct 15;15(20):6314-20
references.pmid: 19808869
references.citation: Dev Cell. 2006 Oct;11(4):575-82
references.pmid: 17011495
references.citation: J Clin Oncol. 2004 Nov 15;22(22):4456-62
references.pmid: 15483017
references.citation: Cell Signal. 2009 Apr;21(4):509-22
references.pmid: 19136059
references.citation: Clin Cancer Res. 2010 Apr 15;16(8):2450-7
references.pmid: 20332327
references.citation: Oncogene. 2007 Dec 10;26(56):7741-8
references.pmid: 18066086
references.citation: Expert Opin Ther Targets. 2010 Nov;14(11):1199-212
references.pmid: 20932174
references.citation: Nat Cell Biol. 1999 Nov;1(7):393-8
references.pmid: 10559981
references.citation: J Biol Chem. 2010 Jun 25;285(26):19802-12
references.pmid: 20427275
references.citation: Genes Dev. 2005 May 1;19(9):1007-12
references.pmid: 15879550
references.citation: Clin Cancer Res. 2010 Mar 15;16(6):1924-37
references.pmid: 20215549